Three-fold Increase in Mass Shootings in Step with Increased Psychiatric Drugging
By Kelly Patricia O’Meara November 19, 2013 The U.S. Attorney General, Eric Holder, recently announced that the rate of mass shootings in the U.S. is…
By Kelly Patricia O’Meara November 19, 2013 The U.S. Attorney General, Eric Holder, recently announced that the rate of mass shootings in the U.S. is…
Patients taking SSRIs were more likely to have obesity, chronic pulmonary disease, and hypothyroidism, which are conditions that could complicate surgery.
Ben Goldacre’s TEDTalk describes the selective bias in research and publishing which strongly favors articles with positive outcomes. In my field of psychiatry, this bias is only the tip of the iceberg. In many cases, the articles are not even written by the scientists whose names appear on them. They are “ghostwritten” by drug company minions.
In my role as a medical expert in product liability lawsuits against drug companies, judges have empowered me to dig into the otherwise secret interiors of drug company data vaults. The following observations have been generated during my forensic investigations and have been documented in my books and scientific articles.
All of the panel members that produced the American Psychiatric Association (APA)’s Practice Guideline for the Treatment of Patients with Major Depressive Disorder had numerous financial ties to drug companies that manufacture antidepressants, raising questions about the trustworthiness of the guideline, a UMass Boston researcher says.
All of the panel members that produced the American Psychiatric Association (APA)’s Practice Guideline for the Treatment of Patients with Major Depressive Disorder had numerous financial ties to drug companies that manufacture antidepressants, raising questions about the trustworthiness of the guideline, a UMass Boston researcher says.